MeiraGTx Holdings plc (MGTX)
NASDAQ: MGTX · Real-Time Price · USD
7.43
-0.15 (-1.98%)
Mar 3, 2026, 4:00 PM EST - Market closed
MeiraGTx Holdings Market Cap
MeiraGTx Holdings has a market cap or net worth of $598.05 million as of March 4, 2026. Its market cap has increased by 14.21% in one year.
Market Cap
598.05M
Enterprise Value
671.27M
1-Year Change
14.21%
Ranking
Category
Stock Price
$7.43
Market Cap Chart
Since June 8, 2018, MeiraGTx Holdings's market cap has increased from $407.76M to $598.05M, an increase of 46.67%. That is a compound annual growth rate of 5.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 598.05M | -6.54% |
| Dec 31, 2025 | 639.90M | 34.45% |
| Dec 31, 2024 | 475.95M | 6.61% |
| Dec 29, 2023 | 446.45M | 41.25% |
| Dec 30, 2022 | 316.07M | -70.05% |
| Dec 31, 2021 | 1.06B | 60.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 631.68M |
| Rigel Pharmaceuticals | 630.58M |
| Zura Bio | 628.08M |
| Lexicon Pharmaceuticals | 627.81M |
| Allogene Therapeutics | 624.75M |
| Alto Neuroscience | 611.70M |
| LB Pharmaceuticals | 607.43M |
| YD Bio | 603.34M |